Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3)
Brazil flag Brazil · Delayed Price · Currency is BRL
1.920
+0.170 (9.71%)
Aug 26, 2026, 5:10 PM GMT-3

BVMF:ONCO3 Cash Flow Statement

Millions BRL. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-3,624-646.19223.6246.26-46.9
Depreciation & Amortization
251.01275.45236.9175.15121.71
Other Amortization
46.3950.9320.47-5.27
Loss (Gain) From Sale of Assets
434.33----
Asset Writedown & Restructuring Costs
1,151724.912.61.961.1
Loss (Gain) From Sale of Investments
497.98----
Loss (Gain) on Equity Investments
-0.187.911.650.54-
Stock-Based Compensation
22.1827.6546.8411.0869.16
Provision & Write-off of Bad Debts
218.18175.15163.2599.3148.71
Other Operating Activities
968.7-175.66-250.16-92.558.96
Change in Accounts Receivable
-281.47-781.08-659.59-676.1-182.05
Change in Inventory
24.47-18.85-42.26-70.29-24.22
Change in Accounts Payable
109.38217.79159.17262.5547.75
Change in Income Taxes
-15.1477.3365.88-49.9819.13
Change in Other Net Operating Assets
78.61-120.19-29.9220.43-77.91
Operating Cash Flow
-118.63-184.85-51.56-271.64-9.28
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-168.12-214.25-311.7-300.18-201.95
Cash Acquisitions
-76.74-213.05-46.36-823.36-402.5
Investment in Securities
1,032-1,283556.09721.37-1,431
Other Investing Activities
5.76-10.5429.8-8.295.93
Investing Cash Flow
793.03-1,721227.83-410.46-2,030

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
310.122,0441,5541,4391,188
Long-Term Debt Repaid
-778.51-1,333-598.06-831.91-544.34
Net Debt Issued (Repaid)
-468.39711.26956.15607.39643.31
Issuance of Common Stock
1.091,5002052.671,788
Repurchase of Common Stock
-3.69--33.74-65.02-177.09
Common Dividends Paid
-36.78-11.66-59.71-18.29-26.4
Other Financing Activities
-210.02-294.19-956.29-117.93-393.48
Financing Cash Flow
-717.781,905111.42408.821,835

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
2.180.57-0.19-0.350.42
Net Cash Flow
-41.20.04287.5-273.63-204.05

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-286.75-399.1-363.26-571.82-211.23
Free Cash Flow Growth
-----
Free Cash Flow Margin
-5.00%-6.41%-6.62%-13.99%-7.82%
Free Cash Flow Per Share
-0.33-0.65-0.68-1.07-0.51
Levered Free Cash Flow
-467.4112.91-615.49-329.02-161.29
Unlevered Free Cash Flow
-62.33468.01-263.37-22.7-64.81

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
689.64608490.63348.55128.78
Cash Income Tax Paid
50.8381.8295.9860.4433.5
Change in Working Capital
-84.15-624.99-506.73-513.39-217.29